INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

75,408 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$9,941
96 sh
Aug 18, 2026Aug 19, 2026
Page 596 of 1886
← PrevNext →
traded Aug 18, 2026
+1d
SEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$18K
177 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$17K
164 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
54.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

2
FP
Foff Erin PennockChief Medical Officer
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
13.4K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

2
FM
Fruhbeis Todd MichaelDirector
STRRStar Equity Holdings, Inc.
Option exercise
M—
535 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

1
DA
Dasdan AliChief Technology Officer
DBXDROPBOX, INC.
Tax withholding · 10b5-1 plan
F$663K
19.3K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

1
HJ
Herrington Douglas JCEO Worldwide Amazon Stores
AMZNAMAZON COM INC
Option exercise · 10b5-1 plan
M—
9,352 sh
Aug 15, 2026Aug 19, 2026
traded Aug 15, 2026
+4dSEC Form 4

Evidence

1
SM
Starzak Alissa MichelleChief Legal Officer
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$259K
3,333 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

1
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
800 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

0
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
1,000 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Derivative conversion · 10b5-1 plan
C—
1.75M sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

0
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$13K
1,000 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Derivative conversion · 10b5-1 plan
C—
11.8K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

0
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$28K
2,876 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
RJ
Riley JanelChief Accounting Officer
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M$113K
1,667 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Grant or award · 10b5-1 plan
A—
15.3K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Derivative conversion · 10b5-1 plan
C—
1.75M sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

0
SM
Starzak Alissa MichelleChief Legal Officer
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
3,333 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Grant or award · 10b5-1 plan
A—
34.6K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Derivative conversion · 10b5-1 plan
C—
3,939 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

0
HR
Hamady Robert RamseyChief Financial Officer
SMRNUSCALE POWER Corp
Option exercise · 10b5-1 plan
M$0
0 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Option exercise · 10b5-1 plan
M$4,018
11.8K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

0
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Grant or award · 10b5-1 plan
A—
4,711 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
RJ
Riley JanelChief Accounting Officer
NETCloudflare, Inc.
Option exercise · 10b5-1 plan
M—
1,667 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
HR
Hamady Robert RamseyChief Financial Officer
SMRNUSCALE POWER Corp
Option exercise · 10b5-1 plan
M—
20.0K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
31.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

0
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,876 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise · 10b5-1 plan
M—
80.8K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Tax withholding · 10b5-1 plan
F$107K
972 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
37.9K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

0
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
11.8K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

0
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Option exercise · 10b5-1 plan
M$19K
80.8K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

58
MF
Musser ForySenior VP, Development
VGVenture Global, Inc.
Open-market sale
SELL$6.27M
447.5K sh
Aug 14, 2026Aug 18, 2026
traded Aug 14, 2026
+4dSEC Form 4

Evidence

55
MF
Musser ForySenior VP, Development
VGVenture Global, Inc.
Open-market sale
SELL$309K
22.0K sh
Aug 17, 2026Aug 18, 2026
traded Aug 17, 2026
+1dSEC Form 4

Evidence

55
PJ
Poletti Samuel JonasChief Strategy & M&A Officer
AMRZAmrize Ltd
Open-market purchase
BUY$118K
2,510 sh
Aug 17, 2026Aug 18, 2026
traded Aug 17, 2026
+1dSEC Form 4

Evidence

53
PD
PM Alpha II DAC10% Owner
AB-LENDAB Private Lending Fund
Open-market purchase
BUY$1.33M
53.1K sh
Mar 2, 2026Aug 18, 2026
traded Mar 2, 2026
+169dSEC Form 4

Evidence

49
AR
Allen RuthChief Human Resources Officer
NWSNEWS CORP
Open-market sale
SELL$624K
21.5K sh
Aug 17, 2026Aug 18, 2026
traded Aug 17, 2026
+1dSEC Form 4

Evidence

49
CL
Chandrashekar LavanyaChief Financial Officer
NWSNEWS CORP
Open-market sale
SELL$510K
17.8K sh
Aug 17, 2026Aug 18, 2026
traded Aug 17, 2026
+1dSEC Form 4

Evidence

46
DJ
Delany JulianChief Technology Officer
NWSNEWS CORP
Open-market sale
SELL$50K
1,747 sh
Aug 17, 2026Aug 18, 2026
traded Aug 17, 2026
+1dSEC Form 4

Evidence